Overview

Cavernous Transformation of Portal Vein： Etiology, Diagnosis, Management and Prognosis

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
To observe the etiology, diagnosis, management and prognosis of cavernous transformation of portal vein.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Montelukast
Criteria
Inclusion Criteria:

- All patients with CTPV.

Exclusion Criteria:

- Patients with known severe dysfunction of heart, lung, brain, kidney and other vital
organs.